Azacytidine Combined With Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic T-cell Lymphoma: a Multicenter Single Arm Phase II Study
Latest Information Update: 07 May 2024
At a glance
- Drugs Azacitidine (Primary) ; Tucidinostat (Primary)
- Indications T-cell lymphoma
- Focus Therapeutic Use
Most Recent Events
- 07 May 2024 New trial record